Welcome to PharmVIP (Pharmacogenomic Variant Analysis and Interpretation Platform)

PharmVIP is designed to be a one-stop platform for pharmacogenomic variant analysis and interpretation in individuals. It consists of three data analysis modules from which user can select one or more modules in the same analysis run. First, the Guideline module is used for allele prediction in genes which have information of CPIC (Clinical Pharmacogenetics Implementation Consortium) drug dosing guidelines. These include gene-drug pairs with strong association between genotypes and drug response phenotypes. PharmVIP will report the predicted allele of each gene with the corresponding CPIC recommendation. The second module is for HLA allele prediction. The alleles of all HLA genes predicted using different methods will be listed with the associated adverse drug reactions reported in the published studies, if available. The third module focuses on the identification of variants (single nucleotide polymorphisms, insertions, deletions) in pharmacogenes and the prediction of their effects to gene function. This integrated pharmacogenomics analysis platform is useful for researchers in identifying variants/alleles in all pharmocogenes and interpreting their consequences in terms of gene function, associated adverse drug reactions, drug response and dosing recommendations.

PharmVIP is offered to the public as a free-to-access platform for academic use only. The use and redistribution of PharmVIP's content, in whole or in part, for purposes beyond academia may require a licensing agreement. More details can be found in our Data Usage Policy.

We highly appreciate your engagement with our platform. If you have specific needs for large-scale analyses, encounter any issues, or possess valuable suggestions for improvement, we encourage you to get in touch with us. Your feedback will be very useful in helping us serve you better. Please feel free to contact us. We look forward to working together to enhance the capabilities of PharmVIP and to address your unique requirements. Thank you for your contribution to our ongoing progress and development.